Е. Н. Андреева

ORCID: 0000-0001-8425-0020 · 14 papers in corpus · active 1995-2025

Study types

  • article 13
  • review 1

Condition tags

  • endometriosis 8
  • chronic_pelvic_pain 3
  • dysmenorrhea 1
  • infertility 1
  • dyspareunia 1
review 2025
Efficacy and safety endpoints of dienogest treatment of endometriosis: a systematic review
·doi:10.17816/jowd689557

The synthetic progestogen dienogest has been closely studied in recent years for its therapeutic efficacy in endometriosis. Despite its benign nature, this disease is a serious problem due to its widespread prevalence and negative impact on…

article 2025
Satisfaction of young women with estradiol valerate/dienogest in real clinical practice in Russia: results of prospective multicenter observational study Q-SWAN
·doi:10.14341/brh12748

BACKGROUND : E2V/DNG is widely use in Russian clinical practice, although satisfaction of Russian patients and doctors has not been ever evaluated and analysed.AIM: To evaluate satisfaction in young women (18–35 years old) with a drug conta…

article 2025
The role of an interdisciplinary approach to the treatment of patients with reduced ovarian reserve, premature ovarian insufficiency and mood disorders
·doi:10.14341/probl13576

Diminished ovarian reserve and premature ovarian insufficiency (POI) are the pathologies associated with poor reproductive prognosis, decreased estrogen production, and the development of multiple complications of hypoestrogenism. Currently…

article 2022
Endometriosis and its global impact on a woman’s body
·doi:10.17116/repro20222801154

Проблема эндометриоза приобретает все большее медико-социальное значение в связи с тяжелыми клиническими проявлениями и рецидивирующим течением заболевания, а также негативным влиянием на качество жизни и трудоспособность женщин. Интенсивн…

article 2022
The rarest forms of endometriosis
·doi:10.17116/repro20222801145

Эндометриоз диагностируют у каждой 10-й женщины репродуктивного возраста, и многие акушеры-гинекологи часто встречаются с данным заболеванием в своей клинической практике. Однако эндометриоз остается одним из самых загадочных заболеваний в…

article 2021
Chronic pelvic pain in patients of reproductive age with endometriosis
·doi:10.17116/repro20212701146

Эндометриоз — распространенное самостоятельное заболевание, частота которого у женщин репродуктивного возраста достигает 15% и может служить причиной 10% всех обращений к гинекологу, 40% лапароскопий и 10—15% гистерэктомий. Хроническая таз…

article 2018
Endometriosis: new experience of non-hormonal treatment
·doi:10.17116/repro201824061113
article 2016
Comparative pharmacoeconomic evaluation of the use of specific drug treatment for endometriosis
·doi:10.17116/repro201622278-84
article 2015
The influence of oral combined oral contraceptive with estradiol valerate and dienogest  on hemostatic system
·doi:10.17116/repro20152170-73
article 2015
The influence of oral combined oral contraceptive with estradiol valerate and dienogest  on hemostatic system (a review)
·doi:10.17116/repro201521214-17
article 2014
Роль витамина d и мелатонина в патогенезе синдрома поликистозных яичников

The article presents data on new possible mechanisms of pathogenesis of polycystic ovary syndrome. In the past years there have been a lot of studies on the effect of vitamin D on the development of insulin resistance and hyperandrogenism. …

article 2011
Endometriosis: ways of the decision of a problem to the XXI century
·doi:10.14341/brh201123-10

Article is devoted an actual problem of gynecology – to an endometriosis which meets on the average at 12-50 % fertility women with chronic pelvic pain and/or barreness and at 5-35 % of women of reproductive age.Authors states results of re…

article 2008
Ispol'zovanie mikronizirovannogo natural'nogo progesterona v terapii narusheniy menstrual'nogo tsikla u devushek s sakharnym diabetom 1 tipa v sochetanii s gipertriglitseridemiey
·doi:10.14341/2072-0351-5760

Цель. Сравнительный анализ эффективности гестагенов с пероральным и парентеральным (интравагинальным) путем введения (дидрогестерон с пероральным путем введения, микронизированный натуральный прогестерон с парентеральным путем введения) в к…

article 1995
[The determination of CA-125, CA-19-9 and CEA antigens in gynecologic patients for differential diagnosis and the assessment of the efficacy of surgical treatment and subsequent monitoring].
Akusherstvo i ginekologiia

Tumor markers CA 125, CA 19-9, and carcinoembryonic antigen (CEA) were measured in the blood sera of 396 inpatients of different age. In 139 patients the measurements were carried out over time. Hoffman La Roche enzyme immunoassay test kits…